article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

” Patients were most likely to report overall reductions in pain and overall improvements in their quality of life following cannabis therapy. … Future studies should aim to compare medical cannabis to the standard therapy of fibromyalgia, to establish the proper place of cannabis in fibromyalgia therapeutic arsenal.”

Patients 279
article thumbnail

Nevada: Governor Signs Medical Cannabis Expansion Measure

NORML

Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. For more information on pending legislation, visit NORML’s ‘Take Action Center.’ The act becomes effective on July 1, 2019. ’

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MAPS Is Pushing For FDA Approval Of MDMA-Assisted Therapy

Veriheal

MAPS Public Benefit Corporation (PBC), an arm of the Multidisciplinary Association for Psychedelic Studies , has made big strides recently encouraging the Food and Drug Administration (FDA) to consider approving MDMA, also known as molly or ecstasy, for MDMA-assisted therapy.

Therapy 109
article thumbnail

Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

NORML

Authors concluded, “Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”

Patients 362
article thumbnail

CDC Still Soliciting Comments Regarding Chronic Pain Management Solutions

NORML

.” Furthermore, pain patients enrolled in medical cannabis access programs typically report decreasing or even eliminating their use of opiates after initiating cannabis therapy. ” Public comments “are part of the public record and are subject to public disclosure.

article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

.” The study’s findings are consistent with those of numerous other papers reporting that patients typically mitigate their use of opioids following the initiation of cannabis/cannabinoid therapy. Additional information on the relationship between cannabis and opioids is available in the NORML fact-sheet here.

article thumbnail

North Dakota: Governor Signs Medical Cannabis Expansion Laws

NORML

House Bill 1519 significantly expands the pool of patients eligible for medical cannabis therapy to include those diagnosed with autism spectrum disorder, migraine, anorexia, and Tourette Syndrome, among other debilitating conditions. For more information on pending state legislation, visit NORML’s Take Action Center here.

Law 221